Beyond the Probe: Scaling Innovation From the Bench to Product Launch

Watch Episode 168

In drug discovery, tools matter, but so do people. In Episode 168 of the Dr. GPCR Podcast, Dr. Maria Majellaro makes it clear that Celtarys isn’t just a ligand provider. It’s a scientific partner. And that mindset is precisely what makes their new partnership with Dr. GPCR so powerful.

“We don’t just deliver compounds, we solve assay problems.” — Dr. Maria Majellaro

Celtarys specializes in the custom development of fluorescent ligands using a modular chemistry platform. Their method allows researchers to explore different linker positions, tailor activity (agonist or antagonist), and retain biological function, all while skipping the time-consuming synthetic routes common in the field.

But what sets them apart isn’t just chemistry. It’s empathy. Maria emphasizes the importance of genuinely listening to researchers: understanding the biological question first, then building a tool to match it. Whether supporting CROs, academic labs, or pharma teams, Celtarys engages deeply with collaborators to deliver not just reagents but solutions.

“We want to illuminate biology. That’s the mission.” — Dr. Maria Majellaro

Now, as official partners of the Dr. GPCR ecosystem, Celtarys is opening up that model to the broader research community. The goal? Democratize access to high-performance chemical probes and make assay development faster, cheaper, and more customizable.

👉 See how Celtarys can support your drug discovery workflow on the company page.

_______________

Keyword Cloud: GPCR data platform, fluorescent ligands, assay development, GPCR research community, Dr. GPCR ecosystem, GPCR webinar series